Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073339003> ?p ?o ?g. }
- W2073339003 abstract "Catecholamines are the most used vasopressors in vasodilatory shock. However, the development of adrenergic hyposensitivity and the subsequent loss of catecholamine pressor activity necessitate the search for other options. Our aim was to evaluate the effects of vasopressin and its analog terlipressin compared with catecholamine infusion alone in vasodilatory shock.A systematic review and meta-analysis of publications between 1966 and 2011 was performed. The Medline and CENTRAL databases were searched for studies on vasopressin and terlipressin in critically ill patients. The meta-analysis was limited to randomized controlled trials evaluating the use of vasopressin and/or terlipressin compared with catecholamine in adult patients with vasodilatory shock. The assessed outcomes were: overall survival, changes in the hemodynamic and biochemical variables, a decrease of catecholamine requirements, and adverse events.Nine trials covering 998 participants were included. A meta-analysis using a fixed-effect model showed a reduction in norepinephrine requirement among patients receiving terlipressin or vasopressin infusion compared with control (standardized mean difference, -1.58 (95% confidence interval, -1.73 to -1.44); P < 0.0001). Overall, vasopressin and terlipressin, as compared with norepinephrine, reduced mortality (relative risk (RR), 0.87 (0.77 to 0.99); P = 0.04). Vasopressin compared with norepinephrine decreased mortality in adult patients (RR, 0.87 (0.76 to 1.00); P = 0.05) and in patients with septic shock (42.5% vs. 49.2%, respectively; RR, 0.87 (0.75 to 1.00); P = 0.05; number needed to treat, 1 to 15). There was no difference in adverse events between the vasopressin and control groups (RR, 0.98 (0.65 to 1.47); P = 0.92).Vasopressin use in vasodilatory shock is safe, associated with reduced mortality, and facilitates weaning of catecholamines. In patients with septic shock, use of vasopressin compared with norepinephrine may also decrease mortality." @default.
- W2073339003 created "2016-06-24" @default.
- W2073339003 creator A5022505900 @default.
- W2073339003 creator A5027038738 @default.
- W2073339003 creator A5058354208 @default.
- W2073339003 creator A5059119414 @default.
- W2073339003 creator A5072606636 @default.
- W2073339003 creator A5073626826 @default.
- W2073339003 creator A5090576091 @default.
- W2073339003 creator A5091843181 @default.
- W2073339003 date "2012-08-01" @default.
- W2073339003 modified "2023-10-15" @default.
- W2073339003 title "Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials" @default.
- W2073339003 cites W1979697455 @default.
- W2073339003 cites W1993033081 @default.
- W2073339003 cites W2001855995 @default.
- W2073339003 cites W2004095374 @default.
- W2073339003 cites W2012079288 @default.
- W2073339003 cites W2015222304 @default.
- W2073339003 cites W2022255724 @default.
- W2073339003 cites W2026695464 @default.
- W2073339003 cites W2028546766 @default.
- W2073339003 cites W2034190048 @default.
- W2073339003 cites W2053140252 @default.
- W2073339003 cites W2058720586 @default.
- W2073339003 cites W2061588724 @default.
- W2073339003 cites W2072635051 @default.
- W2073339003 cites W2082430120 @default.
- W2073339003 cites W2092576934 @default.
- W2073339003 cites W2094412782 @default.
- W2073339003 cites W2098732392 @default.
- W2073339003 cites W2102372841 @default.
- W2073339003 cites W2105985116 @default.
- W2073339003 cites W2108153775 @default.
- W2073339003 cites W2130621776 @default.
- W2073339003 cites W2166144077 @default.
- W2073339003 cites W2313129410 @default.
- W2073339003 cites W3017100980 @default.
- W2073339003 doi "https://doi.org/10.1186/cc11469" @default.
- W2073339003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3890910" @default.
- W2073339003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22889256" @default.
- W2073339003 hasPublicationYear "2012" @default.
- W2073339003 type Work @default.
- W2073339003 sameAs 2073339003 @default.
- W2073339003 citedByCount "107" @default.
- W2073339003 countsByYear W20733390032012 @default.
- W2073339003 countsByYear W20733390032013 @default.
- W2073339003 countsByYear W20733390032014 @default.
- W2073339003 countsByYear W20733390032015 @default.
- W2073339003 countsByYear W20733390032016 @default.
- W2073339003 countsByYear W20733390032017 @default.
- W2073339003 countsByYear W20733390032018 @default.
- W2073339003 countsByYear W20733390032019 @default.
- W2073339003 countsByYear W20733390032020 @default.
- W2073339003 countsByYear W20733390032021 @default.
- W2073339003 countsByYear W20733390032022 @default.
- W2073339003 countsByYear W20733390032023 @default.
- W2073339003 crossrefType "journal-article" @default.
- W2073339003 hasAuthorship W2073339003A5022505900 @default.
- W2073339003 hasAuthorship W2073339003A5027038738 @default.
- W2073339003 hasAuthorship W2073339003A5058354208 @default.
- W2073339003 hasAuthorship W2073339003A5059119414 @default.
- W2073339003 hasAuthorship W2073339003A5072606636 @default.
- W2073339003 hasAuthorship W2073339003A5073626826 @default.
- W2073339003 hasAuthorship W2073339003A5090576091 @default.
- W2073339003 hasAuthorship W2073339003A5091843181 @default.
- W2073339003 hasBestOaLocation W20733390031 @default.
- W2073339003 hasConcept C126322002 @default.
- W2073339003 hasConcept C168563851 @default.
- W2073339003 hasConcept C197934379 @default.
- W2073339003 hasConcept C2776370428 @default.
- W2073339003 hasConcept C2776988256 @default.
- W2073339003 hasConcept C2777628635 @default.
- W2073339003 hasConcept C2778384902 @default.
- W2073339003 hasConcept C2778514916 @default.
- W2073339003 hasConcept C2779393834 @default.
- W2073339003 hasConcept C2780496750 @default.
- W2073339003 hasConcept C2781300812 @default.
- W2073339003 hasConcept C42219234 @default.
- W2073339003 hasConcept C513476851 @default.
- W2073339003 hasConcept C71924100 @default.
- W2073339003 hasConcept C95190672 @default.
- W2073339003 hasConceptScore W2073339003C126322002 @default.
- W2073339003 hasConceptScore W2073339003C168563851 @default.
- W2073339003 hasConceptScore W2073339003C197934379 @default.
- W2073339003 hasConceptScore W2073339003C2776370428 @default.
- W2073339003 hasConceptScore W2073339003C2776988256 @default.
- W2073339003 hasConceptScore W2073339003C2777628635 @default.
- W2073339003 hasConceptScore W2073339003C2778384902 @default.
- W2073339003 hasConceptScore W2073339003C2778514916 @default.
- W2073339003 hasConceptScore W2073339003C2779393834 @default.
- W2073339003 hasConceptScore W2073339003C2780496750 @default.
- W2073339003 hasConceptScore W2073339003C2781300812 @default.
- W2073339003 hasConceptScore W2073339003C42219234 @default.
- W2073339003 hasConceptScore W2073339003C513476851 @default.
- W2073339003 hasConceptScore W2073339003C71924100 @default.
- W2073339003 hasConceptScore W2073339003C95190672 @default.
- W2073339003 hasIssue "4" @default.
- W2073339003 hasLocation W20733390031 @default.
- W2073339003 hasLocation W20733390032 @default.